Theravance Biopharma Inc ( TBPH) - Key Metrics

TBPH Revenue per Share metrics
Date Revenue per Share Net Income per Share Operating Cash Flow Free Cash Flow per Share
2026Q1 ? ? ? ?
2025Q4 $0.90 $1.20 -$0.12 -$0.12
2025Q3 $0.40 $0.07 -$0.13 -$0.13
2025Q2 $0.52 $1.09 $4.15 $4.15
2025Q1 $0.31 -$0.27 $0.87 $0.87

TBPH Payout ratio and Price per Earnings ratio
Date Payout ratio PE ratio
2026Q1 ? ?
2025Q4 ? 3.90
2025Q3 ? 51.01
2025Q2 ? 2.52
2025Q1 ? -8.17

TBPH Free Cash Flow Yield and Dividend Yield
DateFree Cash Flow YieldDividend Yield
2026Q1 8.80% ?
2025Q4 -0.64% ?
2025Q3 -0.88% ?
2025Q2 37.59% ?
2025Q1 9.70% ?

TBPH

Price: $16.86

52 week price:
10.82
21.03

Payout Ratio Range:
-661.83%
-457.78%

Earnings Per Share: 2.23 USD

P/E Ratio: 7.41

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: Cayman Islands

Volume: 260600

Ebitda: -62.9 million

Market Capitalization: 881.1 million

Links: